Bench-to-Bench Bottlenecks in Translation

See allHide authors and affiliations

Science Translational Medicine  20 Aug 2014:
Vol. 6, Issue 250, pp. 250fs32
DOI: 10.1126/scitranslmed.3009000


Transfer of biopharmaceutical inventions between firms has bottlenecks in upstream development that suggest a role for repurposing mechanisms well before the clinical trials stage.

View Full Text

Stay Connected to Science Translational Medicine